Walleye Capital
PFE icon

Walleye Capital’s Pfizer PFE Stock Holding History

Walleye Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2M Buy
2,417,136
+1,346,650
+126% +$35.2M 0.21% 53
2026
Q1 		$30.1M Buy
1,070,486
+596,980
+126% +$15.9M 0.13% 95
2025
Q4 		$11.8M Sell
473,506
-746,663
-61% -$18.8M 0.04% 546
2025
Q3 		$31.1M Buy
1,220,169
+460,173
+61% +$11.4M 0.12% 128
2025
Q2 		$18.4M Buy
759,996
+523,541
+221% +$12.2M 0.07% 266
2025
Q1 		$5.99M Sell
236,455
-967,046
-80% -$25.3M 0.03% 682
2024
Q4 		$31.9M Buy
1,203,501
+371,542
+45% +$10.1M 0.08% 198
2024
Q3 		$24.1M Sell
831,959
-31,479
-4% -$918K 0.05% 274
2024
Q2 		$24.2M Buy
863,438
+284,003
+49% +$7.82M 0.04% 291
2024
Q1 		$16.1M Sell
579,435
-20,325
-3% -$564K 0.03% 542
2023
Q4 		$17.3M Buy
599,760
+409,524
+215% +$12.4M 0.04% 398
2023
Q3 		$6.31M Buy
+190,236
New +$6.73M 0.02% 873
2020
Q3 		– Sell
-7,188
Closed -$223K – 935
2020
Q2 		$223K Buy
+7,188
New +$244K 0.05% 401
2019
Q4 		– Sell
-349
Closed -$12K – 2151
2019
Q3 		$12K Buy
+349
New +$12.7K ﹤0.01% 1765

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Walleye Capital's PFE Position: Q2 2026 in Review

Walleye Capital increased its Pfizer (PFE) stake by 126% in Q2 2026, buying an estimated $35.2M and bringing the position to 2,417,136 shares worth $58.2M. The position accounts for 0.21% of the portfolio, ranked #53.

Walleye Capital first reported a position in PFE in Q3 2019 and has held it in 14 quarters since. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Walleye Capital held 2,417,136 shares of Pfizer worth $58.2M as of Q2 2026.
  • Walleye Capital bought 1,346,650 Pfizer shares in Q2 2026, an estimated $35.2M.
  • Pfizer made up 0.21% of Walleye Capital's portfolio in Q2 2026, its #53 holding.
  • Walleye Capital first reported a position in Pfizer in Q3 2019 and has held it in 14 quarters since.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.